| 1 |
30057314 | Direct and rapid identification of T315I-Mutated BCR-ABL expressing leukemic cells using infrared microspectroscopy. | 2018 Sep 10 |
1 |
| 2 |
27144331 | Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis. | 2016 Jun 14 |
1 |
| 3 |
26217035 | c-Abl-mediated tyrosine phosphorylation of JunB is required for Adriamycin-induced expression of p21. | 2015 Oct 1 |
6 |
| 4 |
26218127 | Coupled delivery of imatinib mesylate and doxorubicin with nanoscaled polymeric vectors for a sustained downregulation of BCR-ABL in chronic myeloid leukemia. | 2015 Feb |
2 |
| 5 |
26618175 | Doxorubicin Differentially Induces Apoptosis, Expression of Mitochondrial Apoptosis-Related Genes, and Mitochondrial Potential in BCR-ABL1-Expressing Cells Sensitive and Resistant to Imatinib. | 2015 |
1 |
| 6 |
24177958 | c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage. | 2014 Feb |
2 |
| 7 |
23383209 | Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1. | 2013 |
1 |
| 8 |
23441067 | Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression. | 2013 May |
1 |
| 9 |
23892407 | Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells. | 2013 Oct |
2 |
| 10 |
24041959 | Formation of long and winding nuclear F-actin bundles by nuclear c-Abl tyrosine kinase. | 2013 Dec 10 |
4 |
| 11 |
21356308 | Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1. | 2011 Jul |
1 |
| 12 |
22001646 | Nuclear c-Abl-mediated tyrosine phosphorylation induces chromatin structural changes through histone modifications that include H4K16 hypoacetylation. | 2011 Dec 10 |
1 |
| 13 |
17957275 | Combined effects of doxorubicin and STI571 on growth, differentiation and apoptosis of CML cell line K562. | 2007 |
1 |
| 14 |
15846067 | Kinase-addiction and bi-phasic sensitivity-resistance of Bcr-Abl- and Raf-1-expressing cells to imatinib and geldanamycin. | 2005 Apr |
2 |
| 15 |
12359059 | Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs. | 2002 Sep |
1 |
| 16 |
11587211 | The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy. | 2001 Oct |
4 |
| 17 |
10979973 | CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. | 2000 Sep 15 |
2 |